Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abbott
Abbott receives U.S. FDA clearance for Cell-Dyn Ruby hematology instrument
August 18th, 2006
Abbott announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its automated, mid-volume hematology instrument, Cell-Dyn Ruby. With its advanced laser optics, this instrument offers enhanced cellular analysis and greater efficiency for laboratories performing complete blood counts (CBCs), a test routinely ordered by doctors to assess a patient's overall health and to screen for a variety of disorders such as anemia and infection. A key facet of Cell-Dyn Ruby is its use of laser light to differentiate cellular components. Known as Multi-Angle Polarized Scatter Separation (MAPSS), this all-optical technology provides...
Source: Biotech Law Weekly (2006-08-18)
|
